The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-5-((4-((2-Hydroxy-1-phenylethyl)amino)-5-(5-methyl-1,3,4-oxadiazol-2-yl)pyrimidin-2-yl)amino)-3,3-dimethylisobenzofuran-1(3H)-one ID: ALA4779496
PubChem CID: 142587255
Max Phase: Preclinical
Molecular Formula: C25H24N6O4
Molecular Weight: 472.51
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1nnc(-c2cnc(Nc3ccc4c(c3)C(C)(C)OC4=O)nc2N[C@H](CO)c2ccccc2)o1
Standard InChI: InChI=1S/C25H24N6O4/c1-14-30-31-22(34-14)18-12-26-24(29-21(18)28-20(13-32)15-7-5-4-6-8-15)27-16-9-10-17-19(11-16)25(2,3)35-23(17)33/h4-12,20,32H,13H2,1-3H3,(H2,26,27,28,29)/t20-/m1/s1
Standard InChI Key: DTHDBWPUQXSBEE-HXUWFJFHSA-N
Molfile:
RDKit 2D
35 39 0 0 0 0 0 0 0 0999 V2000
16.7293 -17.9485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7282 -18.7765 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4436 -19.1897 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.1607 -18.7760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1578 -17.9448 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.4417 -17.5353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4393 -16.7096 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.1532 -16.2946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1506 -15.4689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8695 -16.7054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5833 -16.2904 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.8664 -15.0585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8643 -14.2335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1474 -13.8220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4312 -14.2415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4369 -15.0650 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8763 -19.1877 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.5908 -18.7738 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3031 -19.1859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2954 -17.5345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5845 -17.9502 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0163 -17.9460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0199 -18.7687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8035 -19.0195 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2841 -18.3517 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.7975 -17.6884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0491 -16.9020 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.5848 -19.8126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5148 -19.4289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0187 -17.5360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9322 -16.7149 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.1245 -16.5434 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.7117 -17.2587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2645 -17.8720 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.8906 -17.3453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
6 7 1 0
8 7 1 1
8 9 1 0
8 10 1 0
10 11 1 0
9 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 9 1 0
4 17 1 0
17 18 1 0
18 19 2 0
19 23 1 0
22 20 1 0
20 21 2 0
21 18 1 0
22 23 2 0
23 24 1 0
24 25 1 0
25 26 1 0
26 22 1 0
26 27 2 0
24 28 1 0
24 29 1 0
30 31 2 0
31 32 1 0
32 33 2 0
33 34 1 0
34 30 1 0
1 30 1 0
33 35 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 472.51Molecular Weight (Monoisotopic): 472.1859AlogP: 4.13#Rotatable Bonds: 7Polar Surface Area: 135.29Molecular Species: NEUTRALHBA: 10HBD: 3#RO5 Violations: ┄HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.34CX Basic pKa: 4.40CX LogP: 2.71CX LogD: 2.71Aromatic Rings: 4Heavy Atoms: 35QED Weighted: 0.34Np Likeness Score: -0.58
References 1. Degnan AP,Kumi GK,Allard CW,Araujo EV,Johnson WL,Zimmermann K,Pearce BC,Sheriff S,Futran A,Li X,Locke GA,You D,Morrison J,Parrish KE,Stromko C,Murtaza A,Liu J,Johnson BM,Vite GD,Wittman MD. (2021) Discovery of Orally Active Isofuranones as Potent, Selective Inhibitors of Hematopoetic Progenitor Kinase 1., 12 (3): [PMID:33732413 ] [10.1021/acsmedchemlett.0c00660 ]